Abstract
Until the only muscle relaxants available had a long duration of action, the choice was mainly guided by their cardiovascular side effects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McCoy EP, Mirakhur RK, Maddineni VR et al (1996) Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia. Br J Anaesth 76:29–33
Boyd AH, VanMiert MM, Eastwood MB et al (1994) Pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Anaesth 73:P262
Shanks CA, Fragen RJ, Ling D (1993) Continuous intravenous infusion of rocuronium (ORG 9426) in patients receiving balanced, enflurane or isoflurane anaesthesia. Anesthesiology 78: 649–651
Naguib M, Abdulatif M, Al Ghamdi A (1993) Dose response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426) induced neuromuscular blockade. Anesthesiology 79:739–745
Szenoradszky J, Fisher DM, Segredo V et al (1992) Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology 77:899–904
Cooper RA, Maddineni VR, Mirakhur RK et al (1993) Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (ORG 9426) during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 71:222–226
Khalil M, D’Honneur G, Duvaldestin P et. al. (1994) Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology 80:1241–1247
Magorian T, Wood P, Caldwell J et al (1995) The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg 80:754–759
Lien CA, Schmith WD, Embree PB et al (1994) The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/ barbiturate anaesthesia. Anesthesiology 80:1296–1302
Wright PMC, Caldwell JE, Miller RD (1994) Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anaesthetized humans. Anesthesiology 81:1110–1115
Wierda JMKH, Van Den Broek L, Proost JH et al (1993) Time course of action and endotracheal intubating conditions of ORG 9487, a new short acting steroidal muscle relaxant: a comparison with succinylcholine. Anesth Analg 77:579–584
De Bros F, Goudsouzian N, Chakravorty S et al (1994) Pharmacokinetic evaluation of the cis cis isomer, alcohol and ester metabolites of mivacurium during prolonged infusions in neurosurgical patients. Anesthesiology 81:A1085
Naguib M, El-Gammal M, Daoud W et al (1995) Human plasma cholinesterase for antagonism of prolonged mivacurium induced neuromuscular blockade. Anesthesiology 83: 1288–1291
Ostergaard D, Jensen FS, Viby-Mogensen J (1995) Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase. Anesthesiology 82:1295–1298
Hart PS, McCarthy GJ, Brown R et al (1995) The effect of plasma cholinesterase activity on mivacurium infusion rates. Anesth Analg 80:760–763
Maddineni VR, Mirakhur RK, McCoy EP (1995) Infusion requirements of mivacurium during balanced anaesthesia and anaesthesia supplemented with halothane, isoflurane or enflurane. Anesthesiology 83:A903
Devlin JC, Head-Rapson AG, Parker CJR et al (1993) Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis. Br J Anaesth 71:227–231
Bell CF, Hunter JM, Jones RS et al (1985) The use of atracurium and vecuronium in patients with oesophageal varices. Br J Anaesth 57:160–168
Platt MW, Munday IT, Merrett KL et al (1994) Mivacurium in young adults and elderly patients. Br J Anaesth 73:263P
Belmont MR, Lien CA, Quessy S et al (1995) The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anaesthesia. Anesthesiology 82: 1139–1146
Lien CA, Belmont MR, Abalos A et al (1995) The cardiovascular effects and histamine releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anaesthesia. Anesthesiology 82:1131–1138
Sorooshian SS, Stafford MA, Hull CJ (1994) Pharmacodynamics of 51W89 in young and elderly patients. Br J Anaesth 73:P275
Mellinghof H, Diefenbach CH, Buzello W (1991) Neuromuscular and cardiovascular properties of ORG 9426. Anesthesiology 75:A807
Levy JK, Davis GK, Duggan J et al (1994) Determination of the hemodynamics and histamine release of rocuronium (ORG 9426) when administered in increased doses under N20/02-sufentanil anaesthesia. Anesth Analg 78:318–321
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Italia
About this paper
Cite this paper
Melloni, C. (1997). Myoresolution. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2296-6_57
Download citation
DOI: https://doi.org/10.1007/978-88-470-2296-6_57
Publisher Name: Springer, Milano
Print ISBN: 978-3-540-75032-1
Online ISBN: 978-88-470-2296-6
eBook Packages: Springer Book Archive